Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: The Atherosclerosis Risk in Communities study

Ulla T. Schultheiss, Natalie Daya, Morgan E. Grams, Jochen Seufert, Michael Steffes, Josef Coresh, Elizabeth Selvin, Anna Köttgen

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background Reduced kidney function is a common public health problem that increases risk for a wide variety of adverse outcomes, making the identification of potentially modifiable factors associated with the development of incident chronic kidney disease (CKD) important. Alterations in the hypothalamic-pituitary-thyroid axis have been linked to reduced kidney function, but the association of thyroid function with the development of incident CKD is largely uncharacterized. Methods Concentrations of thyroid stimulating hormone (TSH), free thyroxine (FT4), triiodothyronine (T3) and thyroid peroxidase antibody (TPOAb) were quantified in 12 785 black and white participants of the ongoing community-based prospective Atherosclerosis Risk in Communities study. Thyroid markers and clinical categories of thyroid dysfunction (euthyroidism, combined subclinical and overt hypothyroidism, combined subclinical and overt hyperthyroidism) were also evaluated for their association with reduced kidney function (estimated glomerular filtration rate <60 mL/min/1.73 m 2) at study baseline and with incident CKD over a median follow-up time of 19.6 years. Results Higher TSH and FT4 as well as lower T3 concentrations were strongly and independently associated with reduced kidney function at study baseline. The clinical entities hypothyroidism and hyperthyroidism were also associated with higher odds of baseline reduced kidney function, but this was not significant. However, none of the markers of thyroid function nor different clinical categories of thyroid dysfunction (hypothyroidism, hyperthyroidism or TPOAb positivity) were associated with incident CKD in adjusted analyses. Conclusions Elevated TSH, FT4 and reduced T3 concentrations were associated with reduced kidney function cross-sectionally. The lack of association with the development of incident CKD suggests that altered thyroid function in the general population is not causally related to CKD development, but screening for thyroidal status may be especially relevant in persons with reduced kidney function.

Original languageEnglish (US)
Pages (from-to)1874-1881
Number of pages8
JournalNephrology Dialysis Transplantation
Volume32
Issue number11
DOIs
StatePublished - Nov 1 2017

Fingerprint

Chronic Renal Insufficiency
Atherosclerosis
Thyroid Gland
Kidney
Population
Thyrotropin
Hyperthyroidism
Hypothyroidism
Iodide Peroxidase
Antibodies
Triiodothyronine
Glomerular Filtration Rate
Thyroxine
Public Health
Biomarkers

Keywords

  • chronic kidney disease
  • cohort study
  • epidemiology
  • thyroid disease
  • thyroid hormones

Cite this

Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population : The Atherosclerosis Risk in Communities study. / Schultheiss, Ulla T.; Daya, Natalie; Grams, Morgan E.; Seufert, Jochen; Steffes, Michael; Coresh, Josef; Selvin, Elizabeth; Köttgen, Anna.

In: Nephrology Dialysis Transplantation, Vol. 32, No. 11, 01.11.2017, p. 1874-1881.

Research output: Contribution to journalArticle

Schultheiss, Ulla T. ; Daya, Natalie ; Grams, Morgan E. ; Seufert, Jochen ; Steffes, Michael ; Coresh, Josef ; Selvin, Elizabeth ; Köttgen, Anna. / Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population : The Atherosclerosis Risk in Communities study. In: Nephrology Dialysis Transplantation. 2017 ; Vol. 32, No. 11. pp. 1874-1881.
@article{b9db0095b62b45ca86f6f046d759f9ab,
title = "Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: The Atherosclerosis Risk in Communities study",
abstract = "Background Reduced kidney function is a common public health problem that increases risk for a wide variety of adverse outcomes, making the identification of potentially modifiable factors associated with the development of incident chronic kidney disease (CKD) important. Alterations in the hypothalamic-pituitary-thyroid axis have been linked to reduced kidney function, but the association of thyroid function with the development of incident CKD is largely uncharacterized. Methods Concentrations of thyroid stimulating hormone (TSH), free thyroxine (FT4), triiodothyronine (T3) and thyroid peroxidase antibody (TPOAb) were quantified in 12 785 black and white participants of the ongoing community-based prospective Atherosclerosis Risk in Communities study. Thyroid markers and clinical categories of thyroid dysfunction (euthyroidism, combined subclinical and overt hypothyroidism, combined subclinical and overt hyperthyroidism) were also evaluated for their association with reduced kidney function (estimated glomerular filtration rate <60 mL/min/1.73 m 2) at study baseline and with incident CKD over a median follow-up time of 19.6 years. Results Higher TSH and FT4 as well as lower T3 concentrations were strongly and independently associated with reduced kidney function at study baseline. The clinical entities hypothyroidism and hyperthyroidism were also associated with higher odds of baseline reduced kidney function, but this was not significant. However, none of the markers of thyroid function nor different clinical categories of thyroid dysfunction (hypothyroidism, hyperthyroidism or TPOAb positivity) were associated with incident CKD in adjusted analyses. Conclusions Elevated TSH, FT4 and reduced T3 concentrations were associated with reduced kidney function cross-sectionally. The lack of association with the development of incident CKD suggests that altered thyroid function in the general population is not causally related to CKD development, but screening for thyroidal status may be especially relevant in persons with reduced kidney function.",
keywords = "chronic kidney disease, cohort study, epidemiology, thyroid disease, thyroid hormones",
author = "Schultheiss, {Ulla T.} and Natalie Daya and Grams, {Morgan E.} and Jochen Seufert and Michael Steffes and Josef Coresh and Elizabeth Selvin and Anna K{\"o}ttgen",
year = "2017",
month = "11",
day = "1",
doi = "10.1093/ndt/gfw301",
language = "English (US)",
volume = "32",
pages = "1874--1881",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population

T2 - The Atherosclerosis Risk in Communities study

AU - Schultheiss, Ulla T.

AU - Daya, Natalie

AU - Grams, Morgan E.

AU - Seufert, Jochen

AU - Steffes, Michael

AU - Coresh, Josef

AU - Selvin, Elizabeth

AU - Köttgen, Anna

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Background Reduced kidney function is a common public health problem that increases risk for a wide variety of adverse outcomes, making the identification of potentially modifiable factors associated with the development of incident chronic kidney disease (CKD) important. Alterations in the hypothalamic-pituitary-thyroid axis have been linked to reduced kidney function, but the association of thyroid function with the development of incident CKD is largely uncharacterized. Methods Concentrations of thyroid stimulating hormone (TSH), free thyroxine (FT4), triiodothyronine (T3) and thyroid peroxidase antibody (TPOAb) were quantified in 12 785 black and white participants of the ongoing community-based prospective Atherosclerosis Risk in Communities study. Thyroid markers and clinical categories of thyroid dysfunction (euthyroidism, combined subclinical and overt hypothyroidism, combined subclinical and overt hyperthyroidism) were also evaluated for their association with reduced kidney function (estimated glomerular filtration rate <60 mL/min/1.73 m 2) at study baseline and with incident CKD over a median follow-up time of 19.6 years. Results Higher TSH and FT4 as well as lower T3 concentrations were strongly and independently associated with reduced kidney function at study baseline. The clinical entities hypothyroidism and hyperthyroidism were also associated with higher odds of baseline reduced kidney function, but this was not significant. However, none of the markers of thyroid function nor different clinical categories of thyroid dysfunction (hypothyroidism, hyperthyroidism or TPOAb positivity) were associated with incident CKD in adjusted analyses. Conclusions Elevated TSH, FT4 and reduced T3 concentrations were associated with reduced kidney function cross-sectionally. The lack of association with the development of incident CKD suggests that altered thyroid function in the general population is not causally related to CKD development, but screening for thyroidal status may be especially relevant in persons with reduced kidney function.

AB - Background Reduced kidney function is a common public health problem that increases risk for a wide variety of adverse outcomes, making the identification of potentially modifiable factors associated with the development of incident chronic kidney disease (CKD) important. Alterations in the hypothalamic-pituitary-thyroid axis have been linked to reduced kidney function, but the association of thyroid function with the development of incident CKD is largely uncharacterized. Methods Concentrations of thyroid stimulating hormone (TSH), free thyroxine (FT4), triiodothyronine (T3) and thyroid peroxidase antibody (TPOAb) were quantified in 12 785 black and white participants of the ongoing community-based prospective Atherosclerosis Risk in Communities study. Thyroid markers and clinical categories of thyroid dysfunction (euthyroidism, combined subclinical and overt hypothyroidism, combined subclinical and overt hyperthyroidism) were also evaluated for their association with reduced kidney function (estimated glomerular filtration rate <60 mL/min/1.73 m 2) at study baseline and with incident CKD over a median follow-up time of 19.6 years. Results Higher TSH and FT4 as well as lower T3 concentrations were strongly and independently associated with reduced kidney function at study baseline. The clinical entities hypothyroidism and hyperthyroidism were also associated with higher odds of baseline reduced kidney function, but this was not significant. However, none of the markers of thyroid function nor different clinical categories of thyroid dysfunction (hypothyroidism, hyperthyroidism or TPOAb positivity) were associated with incident CKD in adjusted analyses. Conclusions Elevated TSH, FT4 and reduced T3 concentrations were associated with reduced kidney function cross-sectionally. The lack of association with the development of incident CKD suggests that altered thyroid function in the general population is not causally related to CKD development, but screening for thyroidal status may be especially relevant in persons with reduced kidney function.

KW - chronic kidney disease

KW - cohort study

KW - epidemiology

KW - thyroid disease

KW - thyroid hormones

UR - http://www.scopus.com/inward/record.url?scp=85034833994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034833994&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfw301

DO - 10.1093/ndt/gfw301

M3 - Article

C2 - 27540046

AN - SCOPUS:85034833994

VL - 32

SP - 1874

EP - 1881

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 11

ER -